Skip to main content
Terug
Watch Compare

enVVeno Medical Corp

Datakwaliteit: 83%
NVNO
NASDAQ Manufacturing Measuring & Analyzing Instruments
€ 11,05
€ 0,00 (0,00%)
Marktkapitalisatie: 7,22 M
Prijs
€ 11,01
Marktkapitalisatie
7,22 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -15,57 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-62,31%
Onder sectorgemiddelde (-54,01%)
ROIC-51,99%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio13,12
Interest CoverageN/A

Waardering

PE (TTM)
-0,37
Boven sectorgemiddelde (-1,49)
P/B Ratio0,25
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -0,4 -1,5
P/B 0,3 1,6
ROE % -62,3 -54,0
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Geen toekomstige schattingen beschikbaar

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q22025 -€ 9,80 -€ 11,55 -17,9%
Q12025 -€ 11,90 -€ 7,70 +35,3%
Q42024 -€ 12,25 -€ 10,50 +14,3%
Q32024 -€ 11,55 -€ 12,25 -6,1%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -19,47 M
ROE -62,31% ROA -56,50%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -15,57 M
ROIC -51,99% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 13,12
Interest Coverage N/A Asset Turnover N/A
Working Capital 29,10 M Tangible Book Value 29,45 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,37 Forward P/E N/A
P/B Ratio 0,25 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -215,75%
Market Cap 7,22 M Enterprise Value 5,67 M
Per Share
EPS (Diluted TTM) -33,06 Revenue / Share N/A
FCF / Share -23,75 OCF / Share -23,75
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 79,98%
SBC-Adj. FCF -19,36 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -19,47 M -21,82 M -23,52 M -24,67 M -16,53 M
EPS (Diluted) -33,06 -1,27 -1,91 — —
Gross Profit — — — — —
Operating Income -20,90 M -23,83 M -25,24 M -24,93 M -16,89 M
EBITDA — — — — —
R&D Expenses 9,98 M 12,25 M 13,58 M 9,91 M 5,73 M
SG&A Expenses 10,92 M 11,58 M 11,66 M 15,02 M 11,16 M
D&A 136.000,0 189.000,0 220.000,0 212.000,0 149.002,0
Interest Expense — — — 161.000,0 18.709,0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 29,56 M 44,95 M 48,64 M 41,66 M 57,70 M
Total Liabilities 2,43 M 2,80 M 2,44 M 2,93 M 3,29 M
Shareholders' Equity 27,13 M 42,16 M 46,20 M 38,73 M 54,40 M
Total Debt — — — — —
Cash & Equivalents 3,07 M 1,75 M 3,62 M 4,56 M 54,73 M
Current Assets 28,83 M 43,73 M 46,92 M 39,44 M 55,04 M
Current Liabilities 2,12 M 2,10 M 1,37 M 1,53 M 1,58 M